FDA names opioids, drug competition as top 2018 policy goals
ModernHealthcare.com-7 hours ago
One of the actions the FDA plans to take to combat the epidemic will be reassessing how the agency evaluates opioid products before and after they reach the market, including consideration of the risk for misuse. On Thursday, the agency placed new restrictions on the use of opioids in children's cold and cough products.
No comments:
Post a Comment